NEW

GE HealthCare Preps for SIR 2024

GE HealthCare will showcase its latest technologies in image guiding solutions, surgery, ultrasound and CT-navigation at the upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting taking place March 23-28 in Salt Lake City, Utah. The...

Samsung Accepts Healthcare Innovator Award

Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business, was awarded HHM Health’s Healthcare Innovator Award

AHRA Co-Founder Passes Away

On March 2, 2024, Louise Broadley passed away at 101 years old. AHRA shared the news via an email and website post that reads, “She was a noble woman, who not only achieved many milestones within the imaging profession, but likewise paved the way for aspiring leaders...

Artificial Intelligence Paper Outlines FDA’s Approach to Protect Public Health and Promote Ethical Innovation

Today, the U.S. Food and Drug Administration (FDA) released its “Artificial Intelligence and Medical Products: How CBER, CDER, CDRH, and OCP are Working Together,” which outlines how FDA’s medical product centers are working together to protect public health while...

Siemens Healthineers MAMMOMAT Revelation Mammography Platform

The MAMMOMAT Revelation Mammography Platform from Siemens Healthineers is engineered to make the difference in early breast cancer detection, workflow, dose and patient comfort. HD Breast Tomosynthesis offers the widest image acquisition angle available at 50 degrees, resulting in the industry’s highest in-plane resolution for improved separation of overlapping breast tissue, and 3D image-quality, improving diagnostic confidence and aiding in earlier cancer detection. HD Breast Biopsy enables one-click targeting of suspicious areas with a +/- 1mm accuracy. The InSpect integrated specimen imaging tool permits imaging and real-time review of biopsy samples at the technologist workstation to improve biopsy workflow, shorten compression time and reduce patient discomfort. Also, the MAMMOMAT Revelation is the first platform to offer automated breast density measurement during a mammogram for immediate, personalized risk stratification and more personalized care. The system’s new VC20 software includes efficiency improvements, reduced system calibration times, and an accelerated booting time, in addition to accelerated exam times via the 50-degree TomoFlow feature. New biopsy accessories include a spacer plate for easier imaging of smaller-breasted patients.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

Open